Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function

Clinical Immunology

Volumn 156, Issue 1, 2015, Pages 43-57

  Wu, Hai Jing ^a   Lo, Yi ^a   Luk, Daniel ^a   Lau, Chak Sing ^a   Lu, Liwei ^a   Mok, Mo Yin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dendritic cells; Regulatory T cell; Tolerogenicity; Vitamin D3

Indexed keywords

ALPHA INTERFERON; CELL THERAPY AGENT; COLECALCIFEROL; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; ANTIINFLAMMATORY AGENT; CALCITRIOL; VITAMIN;

ALTERNATIVELY ACTIVATED DENDRITIC CELL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CELL THERAPY; COCULTURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MEMORY T LYMPHOCYTE; PHENOTYPE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UPREGULATION; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CALCITRIOL; DENDRITIC CELLS; DEXAMETHASONE; FLOW CYTOMETRY; HUMANS; IMMUNOMODULATION; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHENOTYPE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VITAMINS;

EID: 84911912628     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.10.011     Document Type: Article

References (56)

1. Feili-Hariri M., Dong X., Alber S.M., Watkins S.C., Salter R.D., Morel P.A. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999, 48:2300-2308.
2. Faunce D.E., Terajewicz A., Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 2004, 172:1991-1995.
3. Charbonnier L.M., van Duivenvoorde L.M., Apparailly F., Cantos C., Han W.G., Noel D., Duperray C., Huizinga T.W., Toes R.E., Jorgensen C., et al. Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+regulatory T cells. J. Immunol. 2006, 177:3806-3813.
4. Lu L., Thomson A.W. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002, 73:S19-S22.
5. McBride J.M., Jung T., de Vries J.E., Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell. Immunol. 2002, 215:162-172.
6. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002, 195:15-21.
7. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4:24-34.
8. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23:445-449.
9. Penna G., Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
10. Anderson A.E., Sayers B.L., Haniffa M.A., Swan D.J., Diboll J., Wang X.N., Isaacs J.D., Hilkens C.M. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J. Leukoc. Biol. 2008, 84:124-133.
11. Banchereau J., Pascual V., Palucka A.K. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004, 20:539-550.
12. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
13. Ding D., Mehta H., McCune W.J., Kaplan M.J. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 2006, 177:5878-5889.
14. Kis-Toth K., Tsokos G.C. Dendritic cell function in lupus: independent contributors or victims of aberrant immune regulation. Autoimmunity 2010, 43:121-130.
15. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
16. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992, 35:630-640.
17. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000, 67:2-17.
18. Degli-Esposti M.A., Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 2005, 5:112-124.
19. Hoene V., Peiser M., Wanner R. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. J. Leukoc. Biol. 2006, 80:1328-1336.
20. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
21. Spranger S., Javorovic M., Burdek M., Wilde S., Mosetter B., Tippmer S., Bigalke I., Geiger C., Schendel D.J., Frankenberger B. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075. J. Immunol. 2010, 185:738-747.
22. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
23. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 2005, 115:407-417.
24. Kushwah R., Wu J., Oliver J.R., Jiang G., Zhang J., Siminovitch K.A., Hu J. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur. J. Immunol. 2010, 40:1022-1035.
25. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., Marshall B., Chandler P., Antonia S.J., Burgess R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002, 297:1867-1870.
26. Koski G.K., Lyakh L.A., Cohen P.A., Rice N.R. CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit. Rev. Immunol. 2001, 21:179-189.
27. Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 2009, 39:3147-3159.
28. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 1999, 162:6473-6481.
29. Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 2005, 62:45-54.
30. Volchenkov R., Karlsen M., Jonsson R., Appel S. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand. J. Immunol. 2013, 77:246-254.
31. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., Barthlott T., Stockinger B., Wraith D.C., O'Garra A. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 2004, 172:5986-5993.
32. Emmer P.M., van der Vlag J., Adema G.J., Hilbrands L.B. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006, 81:1451-1459.
33. Anderson A.E., Swan D.J., Sayers B.L., Harry R.A., Patterson A.M., von Delwig A., Robinson J.H., Isaacs J.D., Hilkens C.M. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 2009, 85:243-250.
34. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000, 1:199-205.
35. Kimura A., Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 2010, 40:1830-1835.
36. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 2005, 35:1681-1691.
37. Berger T.G., Schulze-Koops H., Schafer M., Muller E., Lutz M.B. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS One 2009, 4:e6645.
38. Kushwah R., Oliver J.R., Zhang J., Siminovitch K.A., Hu J. Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J. Immunol. 2009, 183:7104-7118.
39. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000, 191:423-434.
40. Mevorach D. Systemic lupus erythematosus and apoptosis: a question of balance. Clin. Rev. Allergy Immunol. 2003, 25:49-60.
41. Selenko-Gebauer N., Majdic O., Szekeres A., Hofler G., Guthann E., Korthauer U., Zlabinger G., Steinberger P., Pickl W.F., Stockinger H., et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003, 170:3637-3644.
42. Clark G.J., Gunningham S., Troy A., Vuckovic S., Hart D.N. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999, 98:189-196.
43. Dong X., Lutz W., Schroeder T.M., Bachman L.A., Westendorf J.J., Kumar R., Griffin M.D. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16007-16012.
44. Li M., Zhang X., Zheng X., Lian D., Zhang Z.X., Ge W., Yang J., Vladau C., Suzuki M., Chen D., et al. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J. Immunol. 2007, 178:5480-5487.
45. Zhang Y., Yang H., Xiao B., Wu M., Zhou W., Li J., Li G., Christadoss P. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Mol. Immunol. 2009, 46:657-667.
46. Stoop J.N., Harry R.A., von Delwig A., Isaacs J.D., Robinson J.H., Hilkens C.M. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum. 2010, 62:3656-3665.
47. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
48. Feili-Hariri M., Falkner D.H., Morel P.A. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur. J. Immunol. 2002, 32:2021-2030.
49. Beriou G., Moreau A., Cuturi M.C. Tolerogenic dendritic cells: applications for solid organ transplantation. Curr. Opin. Organ Transplant. 2012, 17:42-47.
50. Berkun Y., Verbovetski I., Ben-Ami A., Paran D., Caspi D., Krispin A., Trahtemberg U., Gill O., Naparstek Y., Mevorach D. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur. J. Immunol. 2008, 38:2896-2904.
51. Ben-Zvi I., Aranow C., Mackay M., Stanevsky A., Kamen D.L., Marinescu L.M., Collins C.E., Gilkeson G.S., Diamond B., Hardin J.A. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010, 5:e9193.
52. Xiong J., He Z., Zeng X., Zhang Y., Hu Z. Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin. Exp. Rheumatol. 2014, 32:174-181.
53. Ferreira G.B., Kleijwegt F.S., Waelkens E., Lage K., Nikolic T., Hansen D.A., Workman C.T., Roep B.O., Overbergh L., Mathieu C. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J. Proteome Res. 2012, 11:941-971.
54. Bossu P., Singer G.G., Andres P., Ettinger R., Marshak-Rothstein A., Abbas A.K. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 1993, 151:7233-7239.
55. Scheinecker C., Bonelli M., Smolen J.S. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J. Autoimmun. 2010, 35:269-275.
56. Fritsch R.D., Shen X., Illei G.G., Yarboro C.H., Prussin C., Hathcock K.S., Hodes R.J., Lipsky P.E. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2184-2197.